Anzeige
Meldung des Tages: Das „Next Butte?“-Setup in Montana - und es ist noch immer eine $15M-Story

AbbVie News

Aktie
WKN:  A1J84E ISIN:  US00287Y1091 US-Symbol:  ABBV Branche:  Pharmazeutika Land:  USA
205,22 $
+0,15 $
+0,07%
176,70 € 20:55:38 Uhr
Depot/Watchlist
Marktkapitalisierung *
345,80 Mrd. €
Streubesitz
24,69%
KGV
21,69
Dividende
5,85 EUR
Dividendenrendite
3,02%
Nachhaltigkeits-Score
46 %
Index-Zuordnung
S&P 500
Weiter aufwärts? Long handeln - Jetzt mit Hebel 8,13: VK2C85
Werbung

AbbVie News

25.04.25 wallstreetONLINE Redaktion
Ihre wichtigsten Termine: Heute im Fokus: Bayer, Continental, Steel Dynamics, AbbVie und Schlumberger
Gut geplant in den Tag. Mit dem wO-​Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine ...
24.04.25 - PR Newswire
AbbVie Submits Biologics License Application to U.S. FDA for TrenibotulinumtoxinE (TrenibotE) for the Treatment of Glabellar Lines
AbbVie Submits Biologics License Application to U.S. FDA for TrenibotulinumtoxinE (TrenibotE) for the Treatment of Glabellar Lines PR Newswire
24.04.25 - PR Newswire
The Gross Law Firm Reminds Cerevel Therapeutics Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 3, 2025 - ABBV
The Gross Law Firm Reminds Cerevel Therapeutics Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 3, 2025 - ABBV PR Newswire
22.04.25 - PR Newswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Cerevel Therapeutics Holdings, Inc.(ABBV) Shareholders
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Cerevel Therapeutics Holdings, Inc.(ABBV) Shareholders PR Newswire
21.04.25 - PR Newswire
The Gross Law Firm Notifies Cerevel Therapeutics Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ABBV
The Gross Law Firm Notifies Cerevel Therapeutics Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ABBV PR Newswire
18.04.25 - PR Newswire
Shareholders that lost money on Cerevel Therapeutics Holdings, Inc.(ABBV) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
Shareholders that lost money on Cerevel Therapeutics Holdings, Inc.(ABBV) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More PR Newswire
17.04.25 - PR Newswire
ABBV LAWSUIT ALERT: The Gross Law Firm Notifies Cerevel Therapeutics Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
ABBV LAWSUIT ALERT: The Gross Law Firm Notifies Cerevel Therapeutics Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline PR Newswire
08.04.25 - Aktienwelt360
Finanzielle Freiheit mit Dividenden? Nimm einfach diese 2 Aktien als Einkommens-Booster!
Bist du auch schon mal belächelt worden, wenn du anderen erzählt hast, dir mit Dividenden eine gewisse finanzielle Unabhängigkeit aufbauen zu wollen? Nimm es diesen Leuten ...
08.04.25 - PR Newswire
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults with Giant Cell Arteritis
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults with Giant Cell Arteritis PR Newswire
31.03.25 - PR Newswire
AbbVie to Host First-Quarter 2025 Earnings Conference Call
AbbVie to Host First-​Quarter 2025 Earnings Conference Call PR Newswire
26.03.25 - PR Newswire
AbbVie Showcases Early Pipeline and Scientific Advances in Oncology at AACR Annual Meeting 2025
AbbVie Showcases Early Pipeline and Scientific Advances in Oncology at AACR Annual Meeting 2025 PR Newswire
26.03.25 - LYNX Analysen
AbbVie mit Kursrückgang – was könnte dahinterstecken?
Der US-​amerikanische Biotechnologie- und Pharmakonzern zeigte sich in den letzten Wochen von seiner positiven Seite. Während es an der Wall Street überaus turbulent zuging, ...
24.03.25 - PR Newswire
Allergan Aesthetics Emphasizes Commitment to Innovation, Science and a Patient Centric Approach at AMWC 2025
Allergan Aesthetics Emphasizes Commitment to Innovation, Science and a Patient Centric Approach at AMWC 2025 PR Newswire

Newssuche

Videos

newspaper
19:40 Uhr -10,80%
Technical Trading: Gold Long nach Absturz
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »